Gottlieb
Biotech leaders at the FierceBiotech Drug Development Forum discussed the drug approval process under U.S. Food and Drug Administration Commissioner Scott Gottlieb.
According to a FiercePharma report, three biotech veterans said they were confident Gottlieb was moving in the right direction, suggesting the U.S. was on the path to faster drug approvals.
“(Gottlieb is) one of the better choices because he actually worked at the FDA before,” Martha Carter, Albireo Pharma chief regulatory officer, said. “He understands how it really works.”
